Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration

3-MP represents a promising new class of thalidomide-like IMiDs with potent anti-inflammatory effects that offers potential for treating TBI and possibly other neurodegenerative diseases possessing a prominent neuroinflammatory component.

Authors

Institutions

Publication Details

Journal
Journal of Biomedical Science
Published
2025-06-16
DOI
https://doi.org/10.1186/s12929-025-01150-w
Citations
4
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
3.19

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration

Ross A. McDevitt, Chirag Patel, Abdul Mannan Baig, David Tweedie et al.
4 citations
Journal of Biomedical Science
interferon and immune responses
3.19
article

Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration

Ross A. McDevitt, Chirag Patel, Abdul Mannan Baig, David Tweedie, Anna R. Carta, Shih‐Chang Hsueh, Nigel H. Greig, Weiming Luo, Ju‐Wan Kim, Neil Vargesson, Buyandelger Batsaikhan, Yu Kyung Kim, Pathik Parekh, Mee Youn Lee, Barry J. Hoffer, Dong Liu, Sun Kim, Dong Seok Kim, Inho Hwang, Warren R. Selman
article en
4 citations

Abstract

3-MP represents a promising new class of thalidomide-like IMiDs with potent anti-inflammatory effects that offers potential for treating TBI and possibly other neurodegenerative diseases possessing a prominent neuroinflammatory component.

Journal of Biomedical ScienceVol. 32(1)
National Institute on Drug Abuse (US), University of Cagliari (IT), University of Aberdeen (GB), Quality Biological (US), Baptist Health South Florida (US), RED Consulting (Norway) (NO), National Institute on Aging (US), Schön Klinik Bad Aibling (DE)
National Institutes of Health, National Institute on Aging
Good health and well-being
Openalex Percentile: Top 8%
interferon and immune responses
3.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.